Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2005
12/29/2005WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer
12/29/2005US20050288231 Biologically active peptides as glutamate receptor inhibitors
12/29/2005US20050287632 form a carboxyl-terminal amide of a desired peptide comprising contacting a substrate polypeptide and a palladium complex, where the palladium complex is a palladium(II) or palladium(IV) complex
12/29/2005US20050287580 Isolating biological modulators from biodiverse gene fragment libraries
12/29/2005US20050287525 bioassay for testing peptides that bind to domain peptides of human immunodeficiency virus type I (HIV-1); peptides used for treating viral diseases
12/29/2005US20050287141 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2005CA2612146A1 Treating cancer
12/29/2005CA2570267A1 Fgfr binding peptides
12/29/2005CA2568601A1 Peptide-based compounds
12/28/2005EP1609107A2 Methods of identifying optimal variants of peptide epitopes
12/28/2005EP1608982A1 Diagnosis of autism
12/28/2005EP1608674A1 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants
12/28/2005EP1608673A2 Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock
12/28/2005EP1608409A2 Peptides selectively lethal to malignant and transformed mammalian cells
12/28/2005EP1581904A3 Novel proteins with altered immunogenicity
12/28/2005EP1434779B1 Cross-linked glycopeptide-cephalosporin antibiotics
12/28/2005EP1082128B1 Lysine containing peptides for treatment of heart disease
12/28/2005EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
12/28/2005EP0991658B1 Dolastatin 15 derivatives
12/28/2005EP0920448B1 Truncated glial cell line-derived neurotrophic factor
12/28/2005EP0662134B1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof
12/28/2005CN1713920A Modified transferrin fusion proteins
12/27/2005US6979671 Preventing an inflammatory or immune disorder in a subject while eliminating or reducing the toxicity associated with the administration of cyclosporin A, comprising systemically administering to said subject a pharmaceutical composition and
12/27/2005US6979549 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
12/27/2005US6979535 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
12/27/2005US6979530 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
12/22/2005WO2005122379A2 Alpha-4 beta-1 integrin ligands for imaging and therapy
12/22/2005WO2005121181A1 Multi-drop tree branching polyethylene glycol-oligopeptides and active derivates and pharmaceutical compounds there of
12/22/2005WO2005121178A2 Immunoaffinity chromatography polyol-responsive monoclonal antibodies
12/22/2005WO2005121168A2 Heparin binding peptide
12/22/2005WO2005121167A1 Monocyte locomotion inhibitory factor
12/22/2005WO2005121166A1 Novel immunointeractive molecules and uses thereof
12/22/2005WO2005121164A1 Process for the preparation of peptides
12/22/2005WO2005120700A2 Peptide purification by means of hard metal ion affinity chromatography
12/22/2005WO2005120552A1 METHODS AND FORMULATIONS OF GnRH/LEUKOTOXIN CHIMERAS FOR TESTOSTERONE SUPPRESSION
12/22/2005WO2005100382B1 Vertebrate peptide modulators of lipid metabolism
12/22/2005WO2005019241A3 Cationic antimicrobial peptides and compositions thereof
12/22/2005US20050282745 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/22/2005US20050282731 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
12/22/2005CA2569662A1 Heparin binding peptide
12/22/2005CA2565678A1 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof
12/22/2005CA2560007A1 Process for the preparation of peptides
12/21/2005EP1606308A2 Tumour-associated peptides binding to mhc molecules
12/21/2005EP1606175A1 Lock for a flat and low pourer provided with a removable element in the form of a laminate of film for a composite package for container openings closed by a nonpermeable film
12/21/2005EP1605963A2 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
12/21/2005EP1605893A2 Trans-membrane-antibody induced inhibition of apoptosis
12/21/2005EP1379547B1 Modified cyclosporin as a pro-drug and use thereof as a medicament
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1261625B1 Memno peptides, a process for their preparation and their use
12/21/2005EP1196442B1 Vgf polypeptides and methods of treating vgf-related disorders
12/21/2005EP0702692B1 Regulation of antigen presentation
12/21/2005CN1711279A Epstein Barr virus peptide epitopes, polyepitopes and delivery system therefor
12/21/2005CN1711069A Use of 3-position cyclosporin derivatives for hair growth
12/21/2005CN1709906A Alpha-intermedin cyclic analog peptide and use thereof
12/21/2005CN1709905A Human stomache cancer endothelial-cell specific combination short peptide series
12/21/2005CN1233185C Method for establishing mobile station connection in cellular telecommunications system
12/20/2005US6977292 Nucleophile-stable thioester generating compounds, methods of production and use
12/20/2005US6977242 Two gonadotropin releasing hormones and a method to isolate the same
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/15/2005WO2005119266A1 Sr-a antagonists
12/15/2005WO2005119230A2 Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
12/15/2005WO2005118799A1 Ovine hyaluronidase
12/15/2005WO2005118634A2 Helical peptidomimetics with enhanced activity against beta-amyloid production
12/15/2005WO2005118630A2 Peptides for the treatment of diabetes
12/15/2005WO2005118624A1 Peptides antagonists for inhibiting heat shock protein (hsp 16.3) of mycobacterium tuberculosis
12/15/2005WO2005118623A1 Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (psp94) family member
12/15/2005WO2005118622A2 Naturally processed measles virus peptides eluted from class ii hla molecules
12/15/2005WO2005118621A2 Omi pdz modulators
12/15/2005WO2005118527A2 Fluorous capping reagents, and methods for peptide purification
12/15/2005WO2005117940A2 Cell death modulation via antagonists of fasl and fas activation
12/15/2005WO2005117935A1 Multiple agent therapy for sexual dysfunction
12/15/2005WO2005090570A9 Therapeutic compositions and methods for treating diseases that involve angiogenesis
12/15/2005WO2005060541A3 Peptides and methods for inducing cellular resistance to infection
12/15/2005WO2005058959A3 Treatment of viral infections
12/15/2005WO2004064787A3 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
12/15/2005WO2004043403A3 Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
12/15/2005US20050277594 Polypeptide for the treatment of cancer and a method for preparation thereof
12/15/2005US20050277588 Low white blood cell titer
12/15/2005US20050277586 Peptide chemically modified with polyethylene glycol
12/15/2005US20050277575 Therapeutic compositions and methods for treating diseases that involve angiogenesis
12/15/2005US20050277165 Novel treatment
12/15/2005US20050277160 peptide or a phage recognizing nanographite structures and thus enabling efficient recognition, binding, separation and alignment of nanographite structures such as carbon nanohorns or carbon nanotubes, an artificial protein or a chimeric molecule comprising the above-described peptide bond
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276811 Natural IgM antibodies and inhibitors thereof
12/15/2005CA2568218A1 Multiple agent therapy for sexual dysfunction
12/15/2005CA2567901A1 Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (psp94) family member
12/15/2005CA2563691A1 Cell death modulation via antagonists of fasl and fas activation
12/15/2005CA2558963A1 Omi pdz modulators
12/14/2005EP1604032A2 Method for detecting prognosis of cancer
12/14/2005EP1603944A1 Amylin aggregation inhibitors and use thereof
12/14/2005EP1603937A2 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases
12/14/2005EP1603512A2 Novel cyclosporins
12/14/2005EP1091975B1 Novel cyclosporin with improved activity profile
12/14/2005CN1706865A Branched polyglycol-amino acid oligopeptide and its active derivative and medicinal composition
12/14/2005CN1231495C Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses
12/14/2005CN1231494C Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and application in medicine
12/14/2005CN1231262C Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising the same
12/13/2005US6974861 Conjestive heart failure; polypeptide
12/13/2005US6974797 Bactericides for drug resistant bacteria
1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 423